19-11420933-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_145045.5(ODAD3):c.1690G>A(p.Glu564Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145045.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ODAD3 | NM_145045.5 | c.1690G>A | p.Glu564Lys | missense_variant | 13/13 | ENST00000356392.9 | NP_659482.3 | |
ODAD3 | NM_001302453.1 | c.1528G>A | p.Glu510Lys | missense_variant | 13/13 | NP_001289382.1 | ||
ODAD3 | NM_001302454.2 | c.1510G>A | p.Glu504Lys | missense_variant | 11/11 | NP_001289383.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ODAD3 | ENST00000356392.9 | c.1690G>A | p.Glu564Lys | missense_variant | 13/13 | 1 | NM_145045.5 | ENSP00000348757.3 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248334Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 134890
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461804Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727206
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2023 | The c.1690G>A (p.E564K) alteration is located in exon 13 (coding exon 13) of the CCDC151 gene. This alteration results from a G to A substitution at nucleotide position 1690, causing the glutamic acid (E) at amino acid position 564 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at